Our trustees
Emma Kane, Chair of Trustees
Emma was first appointed as a trustee for Target Ovarian Cancer in March 2015. She is the Chief Executive of SEC Newgate UK and Deputy Group CEO. She is Vice Chair of The Elton John AIDS Foundation and Chair of its Global Development Board. Emma's stepchildren's mother, Heather Ash, died from ovarian cancer in 2007 at the age of 52.
Raj Bhogaita, Honorary Treasurer
Raj is an accomplished Chief Financial Officer. He has over 30 years' experience in listed (FTSE, Nasdaq), blue chip and private equity organisations including Exova, Invensys, Sony and Unilever. His sector experience includes technology, fast-moving consumer goods, food and beverage, transportation and construction. A number of members of Raj's family have been impacted by cancer, and his wife's grandmother died from a gynaecological cancer.
Joanna Barker MBE
Joanna founded Target Ovarian Cancer in 2008 and has over 30 years' experience in business and finance. Joanna's mother and sister died from ovarian cancer in 2005. She's a lay member of the Council of Durham University, which awarded her an honorary doctorate (D.Litt) in 2012. In 2014 she was awarded an MBE in the Queen's birthday honours.
Sonya Branch
Sonya is General Counsel at the Bank of England and the Executive Director for the Legal Directorate. She's responsible for providing legal advice to both the Bank and its subsidiary, the Prudential Regulation Authority. Sonya has previously played a key advisory role in several government key policy initiatives including the Health and Social Care Act, and was a partner in the corporate department at the global law firm Clifford Chance LLP. She is also a trustee and member of the Audit and Finance Committee of NowTeach, and a former trustee and member of the Audit and Finance Committee of the British Institute of International and Comparative Law.
Miriam Jordan Keane
Miriam is a marketer and communications expert with over 30 years' experience in the UK and international markets. She was the New York-based Chief Brand Officer of Weight Watchers and has held senior positions at Saatchi & Saatchi and British Gas. She is now the Chief Brand Officer at NCS Trust. Miriam sits on the Board of Trustees for Voice 21 and has a Master's in English from Trinity College, Dublin. She lost her mother and one of her closest friends, way too young, to cancers that particularly target women.
Anabel Fielding
Anabel is a successful entrepreneur and business leader with over 30 years' experience working in music, entertainment and luxury events. Anabel has worked in 73 countries around the world, she is known for making ideas happen and for creating and delivering high-quality activations and services. Anabel is a recipient of the First Woman Award for Tourism and Leisure and has helped to raise over £20m for charitable causes. She is a proud champion of LGBTQ+ initiatives and excited to help support Target Ovarian Cancer in achieving our goals.
Directors Emeriti
Our Directors Emeriti are former trustees of the charity who continue to play a key role in the achievements of Target Ovarian Cancer.
Lisa Attenborough
Lisa is Director of Communications at Arla Foods. Lisa has held senior communications positions at major international companies and her experience covers a wide range of sectors and all communications disciplines. She has managed significant strategic initiatives working with boards for 25 years across global plcs, private equity and non-governmental organisations. Previous senior level roles include Premier Foods, Mondi, Marks and Spencer, Siemens, Hilton Hotels and the Financial Times. Lisa's mother died of ovarian cancer in 2008.
Margaret Chamberlain
Margaret is a consultant at the London City law firm Travers Smith LLP, where she was a partner for 25 years. She's a solicitor specialising in the regulation of the financial services industry and has experience in non-profit-making, charity and professional services environments. Margaret is also a trustee of Parkinson's UK. Margaret has lost two beloved friends to ovarian cancer and this drives her to support Target Ovarian Cancer's work on early diagnosis, more research and support for those with ovarian cancer.
